Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 6, Issue 3, 2005, Pages 182-184

  Weydt, Patrick ^a   Hong, Soyon ^a   Witting, Anke ^b   Möller, Thomas ^a   Stella, Nephi ^b   Kliot, Michel ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoids; Motor neuron disease; Mouse model; Therapy

Indexed keywords

CANNABINOID DERIVATIVE; CANNABINOL; COPPER ZINC SUPEROXIDE DISMUTASE; DRONABINOL; MACROGOL 400; PLACEBO;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DELIVERY SYSTEM; MALE; MINIPUMP; MOTOR NEURON DISEASE; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; NEUROPROTECTION; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; SYMPTOMATOLOGY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MALE; MICE; MICE, TRANSGENIC; PROBABILITY; PSYCHOTROPIC DRUGS; SUPEROXIDE DISMUTASE; SURVIVAL; TETRAHYDROCANNABINOL;

EID: 26444608731     PISSN: 14660822     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820510030149     Document Type: Article

References (12)

1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688-700.
2. Brujin LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723-49.
3. Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG. Drug therapy for amyotrophic lateral sclerosis: where are we now? IDrugs. 2003;6:147-53.
4. Carter GT, Weydt P. Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs. 2002;3:437-40.
5. Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2001;18:264-70.
6. Aiken CT, Tobin AJ, Schweitzer ES. A cell-based screen for drugs to treat Huntington's disease. Neurobiol Dis. 2004;16:546-55.
7. Gelinas D, Miller RG, Abood ME. A pilot study of safety and tolerability of Delta 9-THC (Marinol) treatment for ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl. 1):23.
8. Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2004;21:95-104.
9. Raman C, McAllister SD, Rizvi G, Patel SG, Moore DH, Abood ME. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:33-9.
10. Witting A, Weydt P, Hong S, Kliot M, Moller T, Stella N. Endocannabinoids accumulate in spinal cord of SOD1 transgenic mice. J Neurochem. 2004;89:1555-7.
11. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 1994;264:1772-5.
12. Weydt P, Hong SY, Kliot M, Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport. 2003;14:1051-4.